H
Hidemi Teramoto
Researcher at National Institutes of Health
Publications - 30
Citations - 6541
Hidemi Teramoto is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Signal transduction & GTPase. The author has an hindex of 23, co-authored 30 publications receiving 6409 citations.
Papers
More filters
Journal ArticleDOI
The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathway
Omar A. Coso,Mario Chiariello,Jin-Chen Yu,Hidemi Teramoto,Piero Crespo,Ningzhi Xu,Toru Miki,J. Silvio Gutkind +7 more
TL;DR: It is shown that in COS-7 cells, activated Ras effectively stimulates MAPK but poorly induces JNK activity, which strongly support a critical role for Rac1 and Cdc42 in controlling the JNK signaling pathway.
Journal ArticleDOI
Integrin function: molecular hierarchies of cytoskeletal and signaling molecules.
Shingo Miyamoto,Hidemi Teramoto,Omar A. Coso,J S Gutkind,Peter D. Burbelo,Steven K. Akiyama,Kenneth M. Yamada +6 more
TL;DR: It was necessary to fulfill all four conditions, i.e., integrin aggregation, integrin occupancy, tyrosine kinase activity, and actin cytoskeletal integrity, to achieve integrin- mediated focal accumulation of other cytoskeleton molecules including F- actin and paxillin.
Journal ArticleDOI
Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis.
TL;DR: It is shown that PGE2 stimulates colon cancer cell growth through its heterotrimeric guanine nucleotide-binding protein (G protein)–coupled receptor, EP2, by a signaling route that involves the activation of phosphoinositide 3-kinase and the protein kinase Akt and relieving the inhibitory phosphorylation of β-catenin and activating its signaling pathway.
Journal ArticleDOI
Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors.
TL;DR: These studies identify mechanisms in the signal transduction response to integrins and growth factors that require various combinations of integrin aggregation and ligands for integrin or growth factor receptors, providing opportunities for collaboration between these major regulatory systems.
Journal ArticleDOI
Signaling from the Small GTP-binding Proteins Rac1 and Cdc42 to the c-Jun N-terminal Kinase/Stress-activated Protein Kinase Pathway A ROLE FOR MIXED LINEAGE KINASE 3/PROTEIN-TYROSINE KINASE 1, A NOVEL MEMBER OF THE MIXED LINEAGE KINASE FAMILY
TL;DR: It is found that MLK3 overexpression is sufficient to activate JNK potently without affecting the phosphorylating activity of MAPK or p38, and evidence is presented thatMLK3 binds the GTP-binding proteins Cdc42 and Rac1 in vivo and that MLk3 mediates activation of MEKK-SEK-JNK kinase cascade by Rac1 and CDC42.